SPAC30D11.11 Antibody

What is SPAC30D11.11 and what is its function in fission yeast?

SPAC30D11.11 is a gene in Schizosaccharomyces pombe (fission yeast) that encodes the izh3 protein. Based on phosphoproteome analysis, this protein appears to be phosphorylated at serine 25 (S25), and this phosphorylation is downregulated under certain nutritional or TOR signaling conditions . The gene belongs to the zinc homeostasis family of proteins, which are typically involved in membrane signaling, stress response pathways, and potentially in nutrient sensing. The protein's phosphorylation status changes in response to environmental conditions, suggesting a regulatory role in cellular adaptation mechanisms.

Experimental verification of function typically requires:

• Phenotypic analysis of deletion strains

• Localization studies using tagged versions or antibodies

• Phosphoproteomic analysis under different stress conditions

• Interaction studies with known signaling pathways

How to validate the specificity of a SPAC30D11.11 antibody?

Proper validation of SPAC30D11.11 antibodies is essential for reliable experimental results. A comprehensive validation approach should include:

• Western blot analysis comparing wild-type and izh3 deletion strains (similar to the approach used for Rad22 antibody validation)

• Testing across multiple applications (Western blot, immunofluorescence, immunoprecipitation)

• Peptide competition assays using the immunizing peptide

• Epitope-tagged versions of izh3 as positive controls

• Cross-reactivity assessment with closely related proteins

A rigorous validation experiment should include:

What are the known post-translational modifications of SPAC30D11.11 (izh3) protein?

The phosphoproteome analysis of fission yeast reveals that SPAC30D11.11 (izh3) is phosphorylated at serine 25 (S25) . This site appears to be regulated in response to nutritional conditions or TOR signaling pathways. Current data indicates:

• Downregulation of S25 phosphorylation under specific conditions (indicated by ↓S25 in the phosphoproteome study)

• Potential involvement in the TOR signaling network, given its inclusion in the TOR-responsive phosphoproteome

• Likely additional phosphorylation sites not yet characterized

For comprehensive PTM mapping, researchers should consider:

• Phospho-specific antibody development for S25

• Mass spectrometry analysis under different growth conditions

• Mutagenesis studies (S25A/S25E) to assess functional consequences

• Analysis of kinase/phosphatase interactions

How does SPAC30D11.11 expression and phosphorylation change under different conditions?

Based on the phosphoproteome study data, SPAC30D11.11 (izh3) phosphorylation at S25 is regulated under specific conditions . To investigate expression and phosphorylation changes:

• Carbon source experiments: Compare protein levels and phosphorylation when grown in glucose versus maltose (similar to experiments in search result )

• Nitrogen limitation studies: Assess changes during nitrogen starvation

• Rapamycin treatment: Examine direct TOR inhibition effects

• Cell cycle analysis: Determine if expression/phosphorylation is cell cycle-dependent

A systematic experimental approach would include:

What is the relationship between SPAC30D11.11 phosphorylation and TOR signaling?

The inclusion of SPAC30D11.11 (izh3) in the TOR-responsive phosphoproteome suggests a potential regulatory relationship . Current understanding indicates:

• S25 phosphorylation decreases in response to certain conditions that may involve TOR pathway regulation

• This protein may function downstream of TOR signaling in nutrient-responsive pathways

• The specific kinase/phosphatase systems regulating S25 remain to be identified

To investigate this relationship further:

• Compare phosphorylation in wild-type vs. TOR pathway mutants

• Assess phosphorylation kinetics during rapamycin treatment

• Identify potential kinases using inhibitor studies

• Determine if S25 phosphorylation affects protein interactions or localization

How to optimize immunoprecipitation protocols for SPAC30D11.11 in fission yeast?

Effective immunoprecipitation of SPAC30D11.11 (izh3) requires optimization for the specific properties of this protein and fission yeast cells. A recommended protocol would include:

Cell Lysis and Extract Preparation:

• Harvest exponentially growing cells (similar to methods described in )

• Wash cells twice with cold PBS containing phosphatase inhibitors

• Lyse cells using glass bead disruption in buffer containing:

  • 50 mM HEPES pH 7.5

  • 150 mM NaCl

  • 1% NP-40 or Triton X-100

  • 1 mM EDTA

  • 1 mM PMSF

  • Protease inhibitor cocktail

  • Phosphatase inhibitor cocktail (critical for preserving S25 phosphorylation)

• Clear lysate by centrifugation at 14,000g for 15 minutes at 4°C

Immunoprecipitation Steps:

• Pre-clear lysate with Protein A/G beads for 1 hour

• Incubate with SPAC30D11.11 antibody (typically 2-5 μg per mg of protein) overnight at 4°C

• Add Protein A/G beads and incubate for 2-3 hours

• Wash 4-5 times with lysis buffer

• Elute with SDS sample buffer or acid elution

Critical Controls:

• IgG isotype control

• SPAC30D11.11 deletion strain lysate

• Input sample (typically 5-10% of starting material)

What are the best fixation and permeabilization methods for immunofluorescence with SPAC30D11.11 antibody?

For optimal immunofluorescence detection of SPAC30D11.11 (izh3) in fission yeast, consider the following protocol:

Fixation Options:

• For membrane proteins (if izh3 is membrane-associated):

  • 4% paraformaldehyde in PBS for 15-30 minutes at room temperature

  • Gentle permeabilization with 0.1% Triton X-100 for 5 minutes

• For cytoplasmic proteins:

  • 70% ethanol (-20°C) for 10 minutes

  • Or methanol (-20°C) for 6 minutes

Blocking and Antibody Incubation:

• Block with 5% BSA in PBS for 60 minutes

• Incubate with primary antibody at optimized dilution (typically 1:50 to 1:500 based on similar antibodies ) overnight at 4°C

• Wash 3x with PBS + 0.1% Tween-20

• Incubate with fluorophore-conjugated secondary antibody (1:500-1:1000) for 1 hour at room temperature

• Counterstain with DAPI (nuclear marker) and appropriate markers for co-localization studies

Optimization Parameters:

• Test both fixation methods to determine which better preserves epitope recognition

• Compare different permeabilization conditions (0.1% vs. 0.5% Triton X-100)

• Evaluate multiple antibody dilutions to maximize signal-to-noise ratio

How to troubleshoot non-specific binding when using SPAC30D11.11 antibody?

Non-specific binding is a common challenge with antibodies in fission yeast. A systematic troubleshooting approach includes:

• Optimize Antibody Dilution:

  • Perform titration experiments (1:100, 1:500, 1:1000, 1:5000)

  • Find the optimal concentration that maximizes specific signal while minimizing background

• Modify Blocking Conditions:

  • Test different blocking agents (BSA, non-fat milk, normal serum)

  • Increase blocking time from 1 hour to overnight

  • Add 0.1-0.5% Tween-20 to blocking solution

• Adjust Washing Parameters:

  • Increase number of washes (3x to 5x)

  • Extend washing time (5 minutes to 15 minutes per wash)

  • Try different washing buffers (TBS-T vs. PBS-T)

• Use Genetic Controls:

  • Always include SPAC30D11.11 deletion strain as negative control

  • Use epitope-tagged strain as positive control

• Peptide Competition:

  • Pre-incubate antibody with the immunizing peptide

  • Compare signal with and without peptide competition

Common Issues and Solutions Table:

What controls should be included when performing Western blots with SPAC30D11.11 antibody?

Proper controls are essential for interpreting Western blot results with SPAC30D11.11 antibody. Based on established practices , include:

Essential Controls:

• Positive control: Wild-type S. pombe strain expressing SPAC30D11.11

• Negative control: SPAC30D11.11 deletion strain (similar to the rad22 deletion control shown in )

• Loading control: Anti-tubulin or anti-actin antibody to normalize protein loading

• Molecular weight marker: To confirm the observed band matches the predicted size

Advanced Controls:

• Tagged version: SPAC30D11.11-HA or SPAC30D11.11-GFP strain

• Phosphorylation control: Lambda phosphatase-treated sample (to verify phospho-specific bands)

• Cross-reactivity assessment: Closely related protein overexpression

Example Western Blot Protocol:

• Run 20-40 μg of total protein per lane

• Transfer to PVDF membrane

• Block with 5% non-fat milk in TBS-T

• Incubate with primary antibody (1:500-1:2000 dilution based on validation data)

• Wash 3x with TBS-T

• Incubate with HRP-conjugated secondary antibody

• Develop using ECL substrate

The expected result would show a specific band at the predicted molecular weight in wild-type samples that is absent in the deletion strain, similar to the validation pattern shown for Rad22 antibody .

How to quantitatively analyze SPAC30D11.11 protein levels across different experimental conditions?

Rigorous quantitative analysis of SPAC30D11.11 protein levels requires:

Sample Preparation Considerations:

• Ensure consistent cell densities across samples (measure using particle counter as in )

• Standardize lysis conditions and protein extraction methods

• Quantify total protein concentration using Bradford or BCA assay

• Load equal amounts of protein (20-40 μg) per lane

Quantification Methods:

• Use digital imaging systems rather than film for linear dynamic range

• Analyze band intensity using software (ImageJ, Image Lab, etc.)

• Normalize to loading controls (tubulin, actin, total protein stain)

• Include calibration samples (known quantities) when possible

Statistical Analysis Approach:

• Perform at least three biological replicates

• Calculate mean, standard deviation, and standard error

• Apply appropriate statistical tests (t-test, ANOVA) based on experimental design

• Report fold-change relative to control condition

Advanced Analysis for Phosphorylation Studies:

• Use phospho-specific antibodies when available

• Calculate phospho/total protein ratios

• Consider phosphatase treatments as controls

• Correlate with mass spectrometry data when possible

How can researchers integrate SPAC30D11.11 protein data with other -omics datasets?

Integration of protein-level data with other -omics approaches provides comprehensive insights:

• Transcriptomics Integration:

  • Compare protein levels with mRNA expression

  • Identify post-transcriptional regulation mechanisms

  • Use tools like GeneSpring, R packages, or Perseus

• Phosphoproteomics Correlation:

  • Map antibody-detected phosphorylation to sites identified in mass spectrometry data

  • Analyze kinase prediction algorithms to identify potential regulators

  • Cluster phosphorylation patterns with functionally related proteins

• Interactome Analysis:

  • Compare immunoprecipitation results with published interaction data

  • Validate interactions using reciprocal co-IP or proximity labeling

  • Build interaction networks using Cytoscape or similar tools

• Pathway Mapping:

  • Integrate protein expression/phosphorylation data into pathway analysis

  • Use KEGG, STRING, or other databases to map functional relationships

  • Identify pathway-level perturbations across conditions

This integrated approach enables researchers to place SPAC30D11.11 function within broader cellular contexts and regulatory networks.